Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 155 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes

NCT00821977

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Advanced Clinical Research Pell City, Alabama, United States
  • Horizon Clinical Research Associates, PLLC Gilbert, Arizona, United States
  • Vista Medical Research, Inc Mesa, Arizona, United States
  • Clinical Research Advantage Mesa, Arizona, United States
View all 176 locations
View Trial Details
Completed

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)

NCT00765830

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +10 more
Locations
  • Clinica de Fracturas y Ortopedia Buenos Aires, Argentina
  • Hospital Teodoro Alvarez Buenos Aires, Argentina
  • Instituto de Investigaciones Clinicas de Mar del Plata Buenos Aires, Argentina
  • Instituto Medico Especializado IME Buenos Aires, Argentina
View all 90 locations
View Trial Details
Completed

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency

NCT00616811

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • University of South Alabama Medical Center Mobile, Alabama, United States
  • Anasazi Internal Medicine Phoenix, Arizona, United States
  • University of Arkanasas for Medical Sciences Little Rock, Arkansas, United States
  • Office of William Zigrang Burlingame, California, United States
View all 79 locations
View Trial Details
Completed

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)

NCT00770081

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +10 more
Locations
  • University of South Alabama Medical Center Mobile, Alabama, United States
  • Anasazi Internal Medicine Phoenix, Arizona, United States
  • Sonoran Health Specialists Scottsdale, Arizona, United States
  • Mary K. Richards, MD. PA Little Rock, Arkansas, United States
View all 87 locations
View Trial Details

Related conditions